SCR-LIP-000252 · Claim · machine-readable JSON →
In a longitudinal study of 25 lipedema patients undergoing tumescent liposuction (mean 3 procedures, mean 9,914 mL removed), spontaneous pain VAS decreased from 7.2 to 4.3, quality-of-life VAS improved from 8.4 to 5.2, and CDT scores fell from 20.5 to 13.9 at ~37 months (all p<0.05), with only 1 erysipelas complication in 72 procedures (1.39%) and better sustained outcomes in stage II than stage III.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- moderate (GRADE)
- Evidence
- 1 source(s)
- Answers
- 4 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- Liposuction in the Treatment of Lipedema: A Longitudinal Study — Dadras et al. (2017) ✓ verified — consistent · cohort · 2017 · reading confidence: high
Longitudinal cohort directly evaluating long-term efficacy (pain, QoL, CDT reduction) and safety (low complication rate) of liposuction for lipedema, with significant improvements and stage-dependent durability.
Context (PECO)
Answers these questions
- Is liposuction effective and safe for lipedema? consistent
- What is the recommended overall management of lipedema? refining
- Does liposuction reduce pain in lipedema? consistent
- Does liposuction reduce limb volume in lipedema? consistent
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-06-02 — merged · absorbed duplicate SCR-LIP-000325
- 2026-05-31 — created · auto-ingested for SQ-LIP-000013